The COVID-19 pandemic had a mixed impact on pharma companies so far. During nationwide lockdowns, some companies benefited from the stockpiling of certain …
Shares of Galapagos (GLPG) rose 8.8% on Friday after the company reported positive topline results in the Phase 2a Novesa trial for its …
Gilead Sciences (GILD) has received a complete response letter (CRL) from the U.S.
Gilead Sciences (GILD) and Galapagos NV (GLPG) have announced positive topline results from a Phase 2b/3 trial evaluating the efficacy and safety of …
Gilead Sciences, Inc. (NASDAQ:GILD) and Galapagos NV (ADR) (NASDAQ:GLPG) announced the closing and entry into force of their global license and collaboration agreement …